Immunovant, Inc. Profile Avatar - Palmy Investing

Immunovant, Inc.

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fra…
Biotechnology
US, New York [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Value per Employee (VpE)

Immunovant, Inc. can't present you any valid VpE charts.

Employee Surveys Sample Size: -

There is no qualitative & current survey we can present at the moment.

Talent Acquisition

Permanent Employees Green Cards
Latest 12 Months
Employees
n/A
Wage Range
Min.:$n/A
Avg.:$n/A
Max.:$n/A
High Demand:

Immunovant, Inc. can't present the data

Other Demand
  • Not available for Immunovant, Inc.
Temporary Employees H1Bs
Latest 12 Months
Employees
n/A
Wage Range
Min.:$n/A
Avg.:$n/A
Max.:$n/A
High Demand:

Immunovant, Inc. can't present the data

Other Demand
  • Not available for Immunovant, Inc.

geographical
binding & acquisition

U.S. · Company Locations
Worldwide · Talent Acquisition
End of IMVT's Analysis
CIK: 1764013 CUSIP: 45258J102 ISIN: US45258J1025 LEI: - UEI: -
Secondary Listings
IMVT has no secondary listings inside our databases.